Furthermore, the CRISPRa-based enhancement of endogenous ectodermal dysplasia ectodysplasin (EDA) gene expression in keratinocyte cells and their successful reprogramming into sweat gland cells has also been reported, which is an important aspect of wound-healing therapy [189]. This evidence concerns the gene EDA and ectodermal dysplasia syndrome.